Long Term Follow-Up of Participants Exposed to GSK3377794 (NYESO-1c259 T), a Genetically Engineered NY-ESO-1 Specific T Cell Receptor (208750)

Grants and Contracts Details

StatusFinished
Effective start/end date4/30/20 → 1/11/24

Funding

  • PPD Investigator Services LLC: $21,128.00